Winton Capital »

Oric Pharmaceuticals shares owned by Winton Capital

Quarter-by-quarter ownership of Oric Pharmaceuticals (ORIC) shares owned by Winton Capital from 13F filings

Historical chart of Winton Capital investment in Oric Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Oric Pharmaceuticals held by Winton Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oric Pharmaceuticals by Winton Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $899k 83k 10.83

More positions owned by Winton Capital

Berkshire Hathaway Inc Del Cl A (BRK.A)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Solstice Advanced Matls Com Shs (SOLS)
Kla Corp Com New (KLAC)
Masco Corporation (MAS)
Cme (CME)
CSX Corporation (CSX)
Incyte Corporation (INCY)
Entegris (ENTG)
Crowdstrike Hldgs Cl A (CRWD)
Public Storage (PSA)
AES Corporation (AES)
Powell Industries (POWL)

View all positions for Winton Capital

Top funds holding Oric Pharmaceuticals

Nextech Invest
BlackRock
EcoR1 Capital
T. Rowe Price Associates
Viking Global Investors
Sr One Capital Management
VR Adviser
NEA Management Company
Vanguard Capital Management
AIHC Capital Management
Alkeon Capital Management
State Street Corporation
Column Group
Siren
FMR

View all funds holding Oric Pharmaceuticals